Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Industry Projections to 2016

Publication date: July 2010

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles

» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

The report provides industry landscape, competitive landscape and industry trends information the diabetes care devices industry . The report provides comprehensive data on the major industry developments affecting the industry, and key analytical content on the industry dynamics. The report also reviews the competitive landscape, key new product development and technology offerings.

Scope of the Research

- Key sectors covered include Glucose Monitoring and Insulin Delivery.
- Annualized industry revenues data from 2002 to 2009, projection forward for 7 years to 2016. Firms shares data for 2009.
- Qualitative analysis of key industry trends, industry drivers, and restraints by each category within the diabetes care devices industry .
- The report also covers data on the leading industry players, the competitive landscape, and the leading new product development and technologies.
- Key Companies covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Firms and Novo Nordisk A/S.

Why Should You Get This Report?

- Develop business strategies by understanding the trends and developments that are driving the diabetes care devices industry in China and India.
- Design and develop your product development, industry ing and sales strategies.
- Exploit Merger and Acquisition opportunities by identifying industry players with the most innovative pipeline.
- Develop successful market-entry strategies .
- Identify key players best positioned to take advantage of the emerging industry opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next being thing in the diabetes care devices industry landscape? – Identify, understand and decide.
- Make more informed business decisions from the insightful and in-depth analysis of the diabetes care devices industry and the factors shaping it.

Medical Devices Industry in India

1 Table of contents 3
I. 1 List of Data tables 5
I. 2 List of Charts 6

II Introduction and Overview 7
II. 1 GlobalData Research Guidance 7
3 Disease Data : Diabetes 8
III. 1 Type I Diabetes 8
III. 1.1 Introduction 8
III. 1.2 Etiology, Disease Symptoms and Risk Factors 8
III. 1.3 Pathophysiology 8
III. 1.4 Epidemiology 9
III. 1.5 Device Based Disease Treatment and Management: Insulin Delivery 10
III. 2 Type 2 Diabetes 11
III. 2.1 Introduction 11
III. 2.2 Etiology, Disease Symptoms and Risk Factors 11
III. 2.3 Pathophysiology 12
III. 2.4 Epidemiology 13
III. 2.5 Device Based Disease Treatment and Management: 13

IV Diabetes Care Devices, Emerging March kets: March ket Characterization 15
IV. 1 Diabetes Care Devices, Emerging March kets, Historical data Sales s (USD Million), 2002 – 2009 15
IV. 2 Diabetes Care Devices, Emerging March kets, Forecasted data Sales s (USD Million), 2009 – 2016 16
IV. 3 Diabetes Care Devices, Emerging March kets, Key Market Shares s 17
IV. 4 Diabetes Care Devices, Emerging March kets, Key March ket Trends 20
IV. 4.1 Increased Government Programs for Diabetes Care Awareness 20
IV. 4.2 Localization of Manufacturing of Diabetes Care Devices by Big Players 20
IV. 5 Diabetes Care Devices, Emerging March kets, March ket Dynamics 21
IV. 5.1 March ket Drivers 21
IV. 5.2 March ket Restraints 21

V Glucose Monitoring, Emerging March kets: March ket Characterization 23
V. 1 Glucose Monitoring Strips, Emerging March kets, Historical data Sales s (USD Million), 2002 – 2009 23
V. 2 Glucose Monitoring Strips, Emerging March kets, Forecasted data Sales (USD Million), 2009 – 2016 24
V. 3 Blood Glucose Meters, Emerging March kets, Historical data Sales s (USD Million), 2002 – 2009 25
V. 4 Blood Glucose Meters, Emerging March kets, Forecasted data Sales s (USD Million), 2009 – 2016 26
V. 5 Glucose Monitoring, Emerging March kets, March ket Dynamics 27
V. 5.1 March ket Drivers 27
V. 5.2 March ket Restraints 27
V. 6 Glucose Monitoring, Emerging March kets, Key Market Shares s 28
V. 6.1 Glucose Monitoring, China, Key Market Shares s, 2009 28
V. 6.2 Glucose Monitoring, India, Key Market Shares s, 2009 29
V. 6.3 Glucose Monitoring, Brazil, Key Market Shares s 2009 30

VI Insulin Delivery, Emerging March kets: March ket Characterization 31
VI. 1 Insulin Syringes, Emerging March kets, Historical data Sales s (USD Million), 2002 – 2009 31
VI. 2 Insulin Syringes, Emerging March kets, Forecasted data Sales s (USD Million), 2009 – 2016 32
VI. 3 Insulin Pens, Emerging March kets, Historical data Sales s (USD Million), 2002 – 2009 33
VI. 4 Insulin Pens, Emerging March kets, Forecasted data Sales s (USD Million), 2009 – 2016 34
VI. 5 Insulin Pumps, Emerging March kets, Historical data Sales s (USD Million), 2002 – 2009 35
VI. 6 Insulin Pumps, Emerging March kets, Forecasted data Sales s (USD Million), 2009 – 2016 36
VI. 7 Insulin Pump Accessories, Emerging March kets, Historical data Sales s (USD Million), 2002 – 2009 37
VI. 8 Insulin Pump Accessories, Emerging March kets, Forecasted data Sales s (USD Million), 2009 – 2016 38
VI. 9 Insulin Delivery, Emerging March kets, March ket Dynamics 39
VI. 9.1 March ket Drivers 39
VI. 9.2 March ket Restraints 39
VI. 10 Insulin Delivery, Emerging March kets, Key Market Shares s, 2009 40
VI. 10.1 Insulin Delivery, China, Key Market Shares s, 2009 40
VI. 10.2 Insulin Delivery, India, Key Market Shares s 2009 41
VI. 10.3 Insulin Delivery, Brazil, Key Market Shares s 2009 42

VII Diabetes Care Devices, Emerging March kets: Key March ket Participants 43
VII. 1 Glucose Monitoring Devices March ket 43
VII. 2 Insulin Delivery Devices March ket 43
VII. 3 Firms Profiles 43
VII. 3.1 F. Hoffmann-La Roche Ltd 43
VII. 3.2 LifeScan (Johnson & Johnson) 44
VII. 3.3 Bayer Healthcare 44
VII. 3.4 Abbott Laboratories 44
VII. 3.5 Becton, Dickinson and Firms 45
VII. 3.6 Medtronic 45
VII. 3.7 November o Nordisk 46
VII. 3.8 Other Firms 46

VIII Appendix 47
VIII. 1 Acronyms 47
VIII. 2 Sources 47
VIII. 3 Database 48
VIII. 4 Research Methodology 48
VIII. 5 Secondary Research 49
VIII. 6 Primary Research 49
VIII. 7 Models 50
VIII. 8 Forecasted data s 50
VIII. 9 Expert Panels 50
VIII. 10 GlobalData Consulting 51
VIII. 11 Contact Us 51
VIII. 12 Disclaimer 51

1.1 List of Data tables
Data table 1: Incidence: New Cases of Type 1 Diabetes in Children (under 14 years) 2010 9
Data table 2: Epidemiology: Percent of with Diabetes (20-79 years), 2010 (national) 13
Data table 3: Diabetes Care Devices, Emerging March kets, Historical data Sales s (USD Million), 2002 – 2009 15
Data table 4: Diabetes Care Devices, Emerging March kets, Forecasted data Sales s (USD Million), 2009 – 2016 16
Data table 5: Diabetes Care Devices, China, Key Firms Sales (USD Million), 2009 17
Data table 6: Diabetes Care Devices, India, Key Firms Sales (USD Million), 2009 18
Data table 7: Diabetes Care Devices, Brazil, Key Firms Sales (USD Million), 2009 19
Data table 8: Glucose Monitoring Strips, Emerging March kets, Historical data Sales s (USD Million), 2002 – 2009 23
Data table 9: Glucose Monitoring Strips, Emerging March kets, Forecasted data Sales s (USD Million), 2009 – 2016 24
Data table 10: Blood Glucose Meters, Emerging March kets, Historical data Sales s (USD Million), 2002 – 2009 25
Data table 11: Blood Glucose Meters, Emerging March kets, Forecasted data Sales s (USD Million), 2009 – 2016 26
Data table 12: Glucose Monitoring, China, Key Firms Sales (USD Million), 2009 28
Data table 13: Glucose Monitoring, India, Key Firms Sales (USD Million), 2009 29
Data table 14: Glucose Monitoring, Brazil, Key Firms Sales (USD Million), 2009 30
Data table 15: Insulin Syringes, Emerging March kets, Historical data Sales s (USD Million), 2002 – 2009 31
Data table 16: Insulin Syringes, Emerging March kets, Forecasted data Sales s (USD Million), 2009 – 2016 32
Data table 17: Insulin Pens, Emerging March kets, Historical data Sales s (USD Million), 2002 – 2009 33
Data table 18: Insulin Pens, Emerging March kets, Forecasted data Sales s (USD Million), 2009 – 2016 34
Data table 19: Insulin Pumps, Emerging March kets, Historical data Sales s (USD Million), 2002 – 2009 35
Data table 20: Insulin Pumps, Emerging March kets, Forecasted data s Sales s (USD Million), 2009 – 2016 36
Data table 21: Insulin Pump Accessories, Emerging March kets, Historical data Sales s (USD Million), 2002 – 2009 37
Data table 22: Insulin Pump Accessories, Emerging March kets, Forecasted data Sales s (USD Million), 2009 – 2016 38
Data table 23: Insulin Delivery, China, Key Firms Sales (USD Million), 2009 40
Data table 24: Insulin Delivery, India, Key Firms Sales (USD Million), 2009 41
Data table 25: Insulin Delivery, Brazil, Key Firms Sales (USD Million), 2009 42
Data table 26: F Hoffman-La Roche, Key March keted Products, Emerging March kets, 2010 43
Data table 27: Johnson & Johnson, Key March keted Products, Emerging March kets, 2010 44
Data table 28: Bayer Healthcare, Key March keted Products, Emerging March kets, 2010 44
Data table 29: Abbott Laboratories, Key March keted Products, Emerging March kets, 2010 44
Data table 30: Becton Dickinson & Firms, Key March keted Products, Emerging March kets, 2010 45
Data table 31: Medtronic, Key March keted Products, Emerging March kets, 2010 45
Data table 32: November oNordisk, Key March keted Products, Emerging March kets, 2010 46
Data table 33: Local Diabetes Care Device Firms in China and India 46

1.2 List of Charts
Chart 1: Incidence: New Cases of Type 1 Diabetes in Children (under 14 years) 2010 9
Chart 2: Epidemiology: Percent of with Diabetes (20-79 years), 2010 (national) 13
Chart 3: Diabetes Care Devices, Emerging March kets, Historical data Sales s (USD Million), 2002 – 2009 15
Chart 4: Diabetes Care Devices, Emerging March kets, Forecasted data Sales s (USD Million), 2009 – 2016 16
Chart 5: Diabetes Care Devices, China, Key Market Shares s, 2009 17
Chart 6: Diabetes Care Devices, India, Key Market Shares s, 2009 18
Chart 7: Diabetes Care Devices, Brazil, Key Market Shares s, 2009 19
Chart 8: Glucose Monitoring Strips, Emerging March kets, Historical data Sales s (USD Million), 2002 – 2009 23
Chart 9: Glucose Monitoring Strips, Emerging March kets, Forecasted data Sales s (USD Million), 2009 – 2016 24
Chart 10: Blood Glucose Meters, Emerging March kets, Historical data Sales s (USD Million), 2002 – 2009 25
Chart 11: Blood Glucose Meters, Emerging March kets, Forecasted data Sales s (USD Million), 2009 – 2016 26
Chart 12: Glucose Monitoring, China, Key Market Shares s, 2009 28
Chart 13: Glucose Monitoring, India, Key Market Shares s, 2009 29
Chart 14: Glucose Monitoring, Brazil, Key Market Shares s, 2009 30
Chart 15: Insulin Syringes, Emerging March kets, Historical data Sales s (USD Million), 2002 – 2009 31
Chart 16: Insulin Syringes, Emerging March kets, Forecasted data Sales s (USD Million), 2009 – 2016 32
Chart 17: Insulin Pens, Emerging March kets, Historical data Sales s (USD Million), 2002 – 2009 33
Chart 18: Insulin Pens, Emerging March kets, Forecasted data Sales s (USD Million), 2009 – 2016 34
Chart 19: Insulin Pumps, Emerging March kets, Historical data Sales s (USD Million), 2002 – 2009 35
Chart 20: Insulin Pumps, Emerging March kets, Forecasted data s Sales s (USD Million), 2009 – 2016 36
Chart 21: Insulin Pump Accessories, Emerging March kets, Historical data Sales s (USD Million), 2002 – 2009 37
Chart 22: Insulin Pump Accessories, Emerging March kets, Forecasted data Sales s (USD Million), 2009 – 2016 38
Chart 23: Insulin Delivery, China, Key Market Shares s, 2009 40
Chart 24: Insulin Delivery, India, Key Market Shares s, 2009 41
Chart 25: Insulin Delivery, Brazil, Key Market Shares s, 2009 42
Chart 26: GlobalData Methodology 49

Companies mentionedF. Hoffmann-La Roche Ltd
LifeScan (Johnson & Johnson)
Bayer Healthcare
Abbott Laboratories
Becton, Dickinson and Firms
Medtronic
November o Nordisk
Hangzhou Yikang Biotech Co., Ltd.
Biocare
Zhejiang Guoguang Biochemistry Co., Ltd.
Nanjing Hospital & Homecare Imp. & Exp. Co., Ltd.
Shenzhen Yidatai Industrial Development Co., Ltd.
Changsha Sinocare Corporation
Pulsatom Healthcare Pvt Ltd

Endocrine, Nutritional And Metabolic Diseases in India